154 related articles for article (PubMed ID: 2091022)
1. Design of biologically active, conformationally constrained GnRH antagonists.
Struthers RS; Tanaka G; Koerber SC; Solmajer T; Baniak EL; Gierasch LM; Vale W; Rivier J; Hagler AT
Proteins; 1990; 8(4):295-304. PubMed ID: 2091022
[TBL] [Abstract][Full Text] [Related]
2. Biological and conformational examination of stereochemical modifications using the template melanotropin peptide, Ac-Nle-c[Asp-His-Phe-Arg-Trp-Ala-Lys]-NH2, on human melanocortin receptors.
Haskell-Luevano C; Nikiforovich G; Sharma SD; Yang YK; Dickinson C; Hruby VJ; Gantz I
J Med Chem; 1997 May; 40(11):1738-48. PubMed ID: 9171884
[TBL] [Abstract][Full Text] [Related]
3. Novel cyclic azo-bridged analogs of gonadotropin-releasing hormone.
Fridkin G; Rahimipour S; Ben-Aroya N; Kapitkovsky A; Di-Segni S; Rosenberg M; Kustanovich I; Koch Y; Gilon C; Fridkin M
J Pept Sci; 2006 Feb; 12(2):106-15. PubMed ID: 16059965
[TBL] [Abstract][Full Text] [Related]
4. A novel computer modeling approach to the structures of small bioactive peptides: the structure of gonadotropin releasing hormone.
Gupta HM; Talwar GP; Salunke DM
Proteins; 1993 May; 16(1):48-56. PubMed ID: 8497483
[TBL] [Abstract][Full Text] [Related]
5. Consensus bioactive conformation of cyclic GnRH antagonists defined by NMR and molecular modeling.
Koerber SC; Rizo J; Struthers RS; Rivier JE
J Med Chem; 2000 Mar; 43(5):819-28. PubMed ID: 10715150
[TBL] [Abstract][Full Text] [Related]
6. Design of potent dicyclic (4-10/5-8) gonadotropin releasing hormone (GnRH) antagonists.
Rivier JE; Struthers RS; Porter J; Lahrichi SL; Jiang G; Cervini LA; Ibea M; Kirby DA; Koerber SC; Rivier CL
J Med Chem; 2000 Mar; 43(5):784-96. PubMed ID: 10715147
[TBL] [Abstract][Full Text] [Related]
7. Mono- and bicyclic analogs of parathyroid hormone-related protein. 1. Synthesis and biological studies.
Bisello A; Nakamoto C; Rosenblatt M; Chorev M
Biochemistry; 1997 Mar; 36(11):3293-9. PubMed ID: 9116007
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and molecular modeling of a novel amide-linked cyclic GnRH analogue cyclo(4-9)[Lys4,D-Trp6,Glu9]GnRH: stimulation of gonadotropin gene expression.
Keramida MK; Tselios T; Mantzourani E; Papazisis K; Mavromoustakos T; Klaussen C; Agelis G; Deraos S; Friligou I; Habibi H; Matsoukas J
J Med Chem; 2006 Jan; 49(1):105-10. PubMed ID: 16392796
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and biological activities of cyclic lactam peptide analogues of dynorphine A(1-11)-NH2.
Lung FD; Collins N; Stropova D; Davis P; Yamamura HI; Porreca F; Hruby VJ
J Med Chem; 1996 Mar; 39(5):1136-41. PubMed ID: 8676350
[TBL] [Abstract][Full Text] [Related]
10. Design of monocyclic (1-3) and dicyclic (1-3/4-10) gonadotropin releasing hormone (GnRH) antagonists.
Rivier JE; Porter J; Cervini LA; Lahrichi SL; Kirby DA; Struthers RS; Koerber SC; Rivier CL
J Med Chem; 2000 Mar; 43(5):797-806. PubMed ID: 10715148
[TBL] [Abstract][Full Text] [Related]
11. Antagonist and agonist binding models of the human gonadotropin-releasing hormone receptor.
Söderhäll JA; Polymeropoulos EE; Paulini K; Günther E; Kühne R
Biochem Biophys Res Commun; 2005 Jul; 333(2):568-82. PubMed ID: 15950933
[TBL] [Abstract][Full Text] [Related]
12. Design of potent dicyclic (1-5/4-10) gonadotropin releasing hormone (GnRH) antagonists.
Rivier JE; Jiang G; Struthers RS; Koerber SC; Porter J; Cervini LA; Kirby DA; Craig AG; Rivier CL
J Med Chem; 2000 Mar; 43(5):807-18. PubMed ID: 10715149
[TBL] [Abstract][Full Text] [Related]
13. Constrained corticotropin-releasing factor (CRF) agonists and antagonists with i-(i+3) Glu-Xaa-DXbb-Lys bridges.
Koerber SC; Gulyas J; Lahrichi SL; Corrigan A; Craig AG; Rivier C; Vale W; Rivier J
J Med Chem; 1998 Dec; 41(25):5002-11. PubMed ID: 9836618
[TBL] [Abstract][Full Text] [Related]
14. A single-point slight alteration set as a tool for structure-activity relationship studies of ovine corticotropin releasing factor.
Beyermann M; Fechner K; Furkert J; Krause E; Bienert M
J Med Chem; 1996 Aug; 39(17):3324-30. PubMed ID: 8765516
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and contractile activities of cyclic thrombin receptor-derived peptide analogues with a Phe-Leu-Leu-Arg motif: importance of the Phe/Arg relative conformation and the primary amino group for activity.
Matsoukas JM; Panagiotopoulos D; Keramida M; Mavromoustakos T; Yamdagni R; Wu Q; Moore GJ; Saifeddine M; Hollenberg MD
J Med Chem; 1996 Aug; 39(18):3585-91. PubMed ID: 8784457
[TBL] [Abstract][Full Text] [Related]
16. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and biological evaluation of new cyclic disulfide decapeptides that inhibit the binding of AP-1 to DNA.
Tsuchida K; Chaki H; Takakura T; Yokotani J; Aikawa Y; Shiozawa S; Gouda H; Hirono S
J Med Chem; 2004 Aug; 47(17):4239-46. PubMed ID: 15293995
[TBL] [Abstract][Full Text] [Related]
18. Betidamino acid scan of the GnRH antagonist acyline.
Jiang G; Miller C; Koerber SC; Porter J; Craig AG; Bhattacharjee S; Kraft P; Burris TP; Campen CA; Rivier CL; Rivier JE
J Med Chem; 1997 Nov; 40(23):3739-48. PubMed ID: 9371239
[TBL] [Abstract][Full Text] [Related]
19. A cyclic CCK8 analogue selective for the cholecystokinin type A receptor: design, synthesis, NMR structure and binding measurements.
De Luca S; Ragone R; Bracco C; Digilio G; Aloj L; Tesauro D; Saviano M; Pedone C; Morelli G
Chembiochem; 2003 Nov; 4(11):1176-87. PubMed ID: 14613109
[TBL] [Abstract][Full Text] [Related]
20. Design of novel bicyclic analogues derived from a potent oxytocin antagonist.
Flouret G; Chaloin O; Borovickova L; Slaninová J
J Pept Sci; 2006 Jun; 12(6):412-9. PubMed ID: 16432806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
